Publications by authors named "Vanessa Iris Gutierrez"
Article Synopsis
- Current kidney disease treatments often lack specificity and can be toxic to the whole body.
- A human monoclonal antibody called F1.1 targets a specific part of a collagen protein found in the kidneys, making it a good candidate for delivering treatments directly to damaged areas.
- Experiments showed that when drugs like PGE2 and dexamethasone were linked to F1.1 and given to mice with kidney inflammation, they improved recovery and reduced side effects, suggesting a promising new approach for targeted kidney therapies.